Background: CD4+/CD56+ hematodermic neoplasm (HN) (blastic natural killer (NK)-cell lymphoma) is a rare entity characterized by dense, monomorphous infiltrates of medium-sized cells with blastic appearance and a characteristic immunophenotype (positivity for CD4, CD56 and CD123). The combination of CD4 and CD56 positivity is thought to be so striking that it has been used to name this entity. Methods: Three cases of HN with ambiguous phenotypic profile were included in this study. In all cases, phenotypic, molecular and in situ hybridization studies were carried out. Results: All three cases showed an aberrant phenotype with negativity for CD4. Conclusions: CD4-negative or CD56-negative cases of HN have been rarely reported in the literature and represent a diagnostic problem. Our three cases confirm that CD4 is not always expressed in these neoplasms. The term 'CD4+/CD56+ hematodermic neoplasm' adopted in the World Health Organization-European Organization for Research and Treatment of Cancer classification of cutaneous lymphomas may be misleading and should probably be revised in the light of all data published in the literature. © Blackwell Munksgaard 2008.

CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases / Ascani, S; Massone, C; Ferrara, G; Rongioletti, F; Papini, M; Pileri, S; Cerroni, L.. - In: JOURNAL OF CUTANEOUS PATHOLOGY. - ISSN 0303-6987. - 35:10(2008), pp. 911-915. [10.1111/j.1600-0560.2007.00915.x]

CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases

Rongioletti F;
2008-01-01

Abstract

Background: CD4+/CD56+ hematodermic neoplasm (HN) (blastic natural killer (NK)-cell lymphoma) is a rare entity characterized by dense, monomorphous infiltrates of medium-sized cells with blastic appearance and a characteristic immunophenotype (positivity for CD4, CD56 and CD123). The combination of CD4 and CD56 positivity is thought to be so striking that it has been used to name this entity. Methods: Three cases of HN with ambiguous phenotypic profile were included in this study. In all cases, phenotypic, molecular and in situ hybridization studies were carried out. Results: All three cases showed an aberrant phenotype with negativity for CD4. Conclusions: CD4-negative or CD56-negative cases of HN have been rarely reported in the literature and represent a diagnostic problem. Our three cases confirm that CD4 is not always expressed in these neoplasms. The term 'CD4+/CD56+ hematodermic neoplasm' adopted in the World Health Organization-European Organization for Research and Treatment of Cancer classification of cutaneous lymphomas may be misleading and should probably be revised in the light of all data published in the literature. © Blackwell Munksgaard 2008.
2008
Adult
Aged
Antineoplastic Agents
Biomarkers
Tumor
Bone Marrow Transplantation
CD4 Antigens
CD56 Antigen
Combined Modality Therapy
Humans
Immunophenotyping
In Situ Hybridization
Killer Cells
Natural
Lymphoma
Non-Hodgkin
Male
Radiotherapy
Skin Neoplasms
2734
Histology
2708
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/111627
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 28
social impact